KDM4C
MOLECULAR TARGETlysine demethylase 4C
KDM4C (lysine demethylase 4C) is targeted by 4 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting KDM4C
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | alvespimycin | 3.40 | 29 |
| 2 | 19-((1'S,4'R)-4'-hydroxy-1'-methoxy-2'-oxopentyl)geldanamycin [Supplementary Concept] | 0.69 | 1 |
| 3 | triolimus [Supplementary Concept] | 0.69 | 1 |
| 4 | bdb chembl3786596 us9611221 example 42 us10179769 example 42 us9725441 example 42 us | 0.69 | 1 |
About KDM4C as a Drug Target
KDM4C (lysine demethylase 4C) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 4 compounds with documented KDM4C interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
KDM4C inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.